ePT--the Electronic Newsletter of Pharmaceutical Technology, Oct 4, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
ePT--the Electronic Newsletter of Pharmaceutical Technology, Oct 4, 2012
News
US Science Advisors Issue Report on Innovation in Drug Discovery and Development
By Amy Ritter
The President's Council of Advisors on Science and Technology (PCAST) released a report containing recommendations for boosting innovation in drug discovery and development.
Merck Serono Launches New Spin-off Company; Provides Update on Restructuring
By Patricia Van Arnum
Merck Serono's Asceneuron is the third company to be spun off from the company's Entrepreneur Partnership Program that was launched to mitigate the impact from recent restructuring at its Geneva site.
EMA Aims to Facilitate Biosimilars Development
By Stephanie Sutton
The European Medicines Agency has updated its guidance on biosimilar medicines, with the aim of helping companies to avoid unnecessary repetition of clinical trials.
Week of October 1, 2012: Merck Returns Brinavess Rights to Cardiome; Sigma-Aldrich Expands in Scotland; and More
Merck Returns Brinavess Rights to Cardiome; Sigma-Aldrich Expands in Scotland; and More.
Regulatory Roundup: Week of October 1, 2012
FDA launches BeSafeRx program and releases guidance for industry.

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
40%
Facility/environment problems
0%
Process development problems
10%
Production equipment downtime
10%
Raw material supply problems
20%
Regulatory restrictions
0%
Business decisions to limit production
20%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Click here